The benefits of investments to combat HIV, tuberculosis, and malaria for primary healthcare from 2000 to 2023: An economic modeling analysis

Journal:

PLOS Medicine

Published:

2026-04-09

DOI:

10.1371/journal.pmed.1005036

Affiliations:

5

Authors:

7

Go to article

Institutions	Authors	Share
MRC Centre for Global Infectious Disease Analysis (MRC GIDA), United Kingdom (UK)	2.000000	0.29
Harvard University, United States of America (USA)	2.000000	0.29
Avenir Health, Inc., United States of America (USA)	2.000000	0.29
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom (UK)	1.000000	0.14

Interested in Clinical Sciences?